PTPN11 and breast neoplasm: Consistent with the finding that phosphorylation of SHP-2 on Y279 down-regulates growth factor-induced sustained ERK activation and proliferation through Abl kinase [31], we found GRB2-SHP2pY279 downregulated in breast tumor cells.